Intrinsic Value
Titan Pharmaceuticals, Inc. (TTNP)
$7.1
+0.20 (+0.00%)
| Enterprise Value | -257.67 |
|---|---|
| Net Debt | -6.21 |
| Equity Value | -251.46 |
| Shares Outstanding | 0.75 |
| Equity Value Per Share | -334.39 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt